Research

RAF Current Clinical Trials

Wet Macular Degeneration Trials

ARCHWAY: Lucentis Implant (Port Delivery System) 
InclusionExclusion
Vision ≥ 20/200Pregnancy
Initial diagnosis Wet AMD < 9mos
Scar involving center
Previous retinal surgery/laser
Previous participation wet AMD trial

Bispecific Anti-VEGF anti-ANG2 Antibody Injection 
InclusionExclusion
Vision ≥ 20/200Pregnancy
Initial diagnosis Wet AMD < 9mos
Scar involving center
Previous retinal surgery/laser
Previous participation wet AMD trial

Diabetic Macular Edema Trials

YOSEMITE: Bispecific Anti-VEGF anti-ANG2 Antibody Injection 
InclusionExclusion
Age ≥ 18
Pregnancy
Vision 20/40 - 20/400
Stroke, heart attack < 6 mos

Type 1 or Type 2 Diabetes
Active cancer within 12 mos
DME with no treatment x 12 mosRenal failure, dialysis, renal transplant

DRCR Protocol AC: Trial of Initial Eylea vs Initial Avastin+ Deferred Eylea 
InclusionExclusion
Age ≥ 18
Pregnancy
Vision 20/40 - 20/400
Stroke, heart attack < 6 mos

Type 1 or Type 2 Diabetes
Active cancer within 12 mos
DME with no treatment x 12 mosRenal failure, dialysis, renal transplant

Vitreous Hemorrhage From Proliferative Diabetic Retinopathy Trial

DRCR Protocol AB: Trial of Initial Eylea vs Initial Vitrectomy 
InclusionExclusion
Age ≥ 8
Pregnancy
Type 1 or Type 2 Diabetes
Stroke, heart attack < 6 mos

Willing to undergo surgery
Uncontrolled Hypertension
Vision 20/30 - light perceptionRenal failure, dialysis, renal transplant

The trials are sponsored, so eligible patients will not incur additional costs. We encourage you to refer eligible patients as they would benefit from the studies and help us answer important questions.

If you have a patient with one of these conditions, please call us to make their referral appointment and mention the clinical trial when making the appointment. Please complete our Clinical Trial Referral Form and ask your patient to bring with them to their appointment.

If you are working on a weekend or after 5:00pm, please complete the Clinical Trial Referral Form and fill it out, then FAX it to our office. We will then contact the patient to make the appointment.

For the initial evaluation, the patient will need to provide their own transportation. If they qualify for the trial, then future transportation will be provided by RAF (via Uber or Taxi).

Questions: Contact Janet @ RAF 813.875.6373 ext 239 or email Janet